🇺🇸 FDA
Patent

US 11332722

Development of dengue virus vaccine components

granted A61KA61K2039/5254A61P

Quick answer

US patent 11332722 (Development of dengue virus vaccine components) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14